Shares of CEN Biotech Inc.  will start trading on the OTCQB Venture Market® - World News Report

Shares of CEN Biotech Inc. will start trading on the OTCQB Venture Market® – World News Report

CEN Biotech Inc. (OTCQB:CENBF)

WINDSOR, ONTARIO, CANADA, September 7, 2022 /EINPresswire.com/ — CEN Biotech Inc. (“CEN” or the “Company”) (OTCQB: CENBF), a global holding company specializing in the development of advanced digital media technologies, LED lighting technologies and hemp-based products, announced that its ordinary shares will begin trading on the OTCQB venture market starting September 8, 2022.® (“OTCQB Venture Market”) under the symbol “CENBF”. OTCQB venture market driven OTC Markets Group Inc. designed for American and international companies at the stage of entrepreneurship and development.

In order to be eligible to trade on the OTCQB venture market, companies must meet certain standards, including meeting their reporting obligations in a timely manner and passing an annual review and management certification process. Companies must also meet the $0.01 rate criterion and must not be in bankruptcy. Investors can find real-time quotes and market information of the company on OTC MARKETS.

The company also announced today that it has begun the process of looking to complete the name change and the planned change of direction. The company intends to focus on the digital media and technology space and intends to launch technology products starting in the fall of 2022. As required by the Canadian Business Corporations Act, the Company intends to hold a special shareholder meeting in the future to allow shareholders to comment and vote on the proposed changes.

“We are very pleased that the shares of CEN Biotech Inc. are traded on the OTCQB venture capital market.® and begin the process of changing our name and direction with the intention of becoming a leading digital technology company,” said Brian S. Payne, CEO of CEN Biotech Inc. “We believe this transition from OTC PINK to OTCQB will enable the Company to continue its growth as a public company.”

The timing of the name change and planned change of business direction is subject to many regulatory and legal requirements from regulators in both Canada and the United States, and requires shareholder approval. There can be no assurance that CEN will be able to proceed with the foregoing as planned, or at all.

About company
CEN Biotech Inc. is a global holding company specializing in the development of digital media and LED lighting technologies, as well as hemp-based products. For more information about the company, please visit our website at www.cenbiotechinc.com. Information about the Company can also be found on the Securities and Exchange Commission’s EDGAR website under “Issuer Profile” of CEN Biotech Inc.

Caution regarding forward-looking information
This press release contains “forward-looking” statements. In particular, the words “believe”, “may”, “could”, “should”, “expect”, “anticipate”, “evaluate”, “design”, “propose”, “plan”, “intend”, etc. .Such conventions and expressions are intended to refer to forward-looking statements. Any statements made in this press release about actions, events or events are forward-looking statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions, many of which may be beyond CEN’s control, which could cause actual results to differ from those set forth in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. While CEN believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that its forward-looking statements will prove correct. Potential risks include factors such as the inability to enter into agreements with parties with whom we negotiate, factors that cannot be predicted with certainty, and additional risks and uncertainties that are identified and described in CEN’s reports filed with the Securities and exchanges. Commission (“SEC”). Investors are cautioned that any forward-looking statements are not guarantees of future results and actual results or events may differ materially from those projected. Actual results could differ materially from the forward-looking statements in this press release. The statements made here are as of the date of this press release and any subsequent date should not be relied upon. CEN does not assume and specifically disclaims any obligation to update any forward-looking statements to reflect events, events or circumstances after the date of such statement, except as required by applicable law.

Brian S. Payne, CEO
CEN Biotech Inc.
+1 519-981-0970
[email protected]

.

Tags: , ,
Previous Post
Free strategic leadership training course aims to close gender pay gap for women of color - World News Report
Blog

Free strategic leadership training course aims to close gender pay gap for women of color – World News Report

Next Post

Starfish Partners acquires Direct Recruiters Inc. (DRI) – World News Report

Leave a Reply

Your email address will not be published. Required fields are marked *